Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
04/2014
04/09/2014CN103709146A Quinoline-4-amine derivatives containing benzimidazole structure, as well as preparation method and medical use thereof
04/09/2014CN103709145A Quinolines compound containing hexahydropyrimidone as well as preparation method and application thereof
04/09/2014CN103709144A Pyrimidine derivatives substituted picolyl sulfoxide compound and preparation method thereof
04/09/2014CN103709143A Preparation method of esomeprazole and magnesium salt thereof
04/09/2014CN103709142A Dabigatran intermediate preparation method
04/09/2014CN103709141A Crystal forms and amorphous forms of rabeprazole sodium
04/09/2014CN103709140A Pantoprazole sodium crystal and preparation method thereof
04/09/2014CN103709139A Preparation method of anhydrous dexilant
04/09/2014CN103709138A 5-(fluoroquinolone C3- methylene)3-pyrrolic amide derivative as well as preparation method and application thereof
04/09/2014CN103709102A Spiro ring-containing pleuromutilin antibiotics
04/09/2014CN103709100A Preparation method of 8-chloroquinolone derivatives
04/09/2014CN103709097A 1,3-substituted carbamide or thiourea compound, preparation method thereof, pharmaceutical composition and application
04/09/2014CN103709096A Urea type derivative used as nicotinamide ribose phosphate transferase inhibitor, as well as preparation method and application thereof
04/09/2014CN103709093A Combined-ring-containing pleuromutilin antibiotics
04/09/2014CN103087048B Method for purifying esomeprazole sodium
04/09/2014CN103012375B Pyridyl triazole methyl substituted acridine derivative, preparation method and application thereof
04/09/2014CN102850326B Dabigatran etexilate intermediate, and preparation method and application thereof
04/09/2014CN102712625B Nitrogen-containing heteroaryl derivatives
04/09/2014CN102712596B Secondary 8-hydroxyquinoline-7-carboxamide derivatives
04/09/2014CN102574834B Fluorinated 2,6-dialkyl-3,5-dicyano-4-(1h-indazol-5-yl)-1,4-dihydropyridines and methods of use thereof
04/09/2014CN102516227B Method for flocculating, decolorizing, separating and purifying nicotine
04/09/2014CN102516226B Method for distilling and refining nicotine circularly and nicotine distilling and absorbing device
04/09/2014CN102344446B Cis-nitenpyram analog containing carboxylic acid-substituted methyl ester and preparation method and application thereof
04/09/2014CN102344439B Cis-nitenpyram analogue containing amino acid diol monoester, preparation and application thereof
04/09/2014CN102285963B 3-methoxy pyrazolecarboxamide compound and application thereof
04/09/2014CN102212031B Preparation method of 2-substituted-4-(piperidylmethyl) pyridine
04/09/2014CN102066357B Indoles as modulators of nicotinic acetylcholin receptor subtype alpha-71
04/09/2014CN102026961B 酰胺化合物 Amide compounds
04/09/2014CN101663283B Quinoxaline compounds and use thereof
04/09/2014CN101443314B Aminoquinolones as GSK-3 inhibitors
04/08/2014US8691995 Process
04/08/2014US8691981 Crystalline forms of (S)-1-(4-(5-cyclopropyl-1H-pyrazol-3-ylamino)pyrrolo[1,2-f][1,2,4]triazin-2-yl)-N-(6-fluoropyridin-3-yl)-2-methylpyrrolidine-2-carboxamide
04/08/2014US8691849 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
04/08/2014US8691848 Inhibitors of caspases
04/08/2014US8691847 Benzamides and related inhibitors of factor Xa
04/08/2014US8691846 Piperidine sulphonamide derivatives
04/08/2014US8691821 Oxazolidinones as modulators of mGluR5
04/08/2014US8691816 Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
04/08/2014US8691815 Substituted oxindole derivatives, drugs containing said derivatives and the use thereof
04/08/2014US8691806 Pyrazole derivatives as protein kinase modulators
04/08/2014US8691805 Azetidinyl diamides as monoacylglycerol lipase inhibitors
04/08/2014US8691184 Bcl-2/Bcl-xL inhibitors and therapeutic methods using the same
04/08/2014CA2771885C 1,2-dihydro-2-oxoquinoline compounds as 5-ht4receptor ligands
04/08/2014CA2563607C 4,5-disubstituted-2-aryl pyrimidines
04/08/2014CA2506310C New antagonist derivatives for the vitronectin receptor, their preparation method, their application as medication and the pharmaceutical compositions containing them
04/03/2014WO2014052619A1 Piperidine derivatives and compositions as modulators of gpr119 activity
04/03/2014WO2014052398A1 Inhibitor of beta-secretase
04/03/2014WO2014052379A1 Substituted cyclopropyl compounds
04/03/2014WO2014051939A1 Phenicol antibacterial agents
04/03/2014WO2014050911A1 Metal complex dye, photoelectric conversion element, dye-sensitized solar cell, dye solution, and dye-adsorbed electrode
04/03/2014WO2014050781A1 Ret inhibitor
04/03/2014WO2014050446A1 Pigment composition, colored curable composition, color filter for solid-state imaging element, method for producing same, solid-state imaging element, pigment dispersion composition, method for producing same, and compound
04/03/2014WO2014050084A1 Novel phenylacetamide compound and pharmaceutical containing same
04/03/2014WO2014049586A2 Process for the preparation of dabigatran etexilate or pharmaceutically acceptable salt thereof
04/03/2014WO2014049585A2 Process for the preparation of dabigatran etexilate or pharmaceutically acceptable salt thereof
04/03/2014WO2014049578A1 New anti-invasive compounds
04/03/2014WO2014049488A1 Benzamide and heterobenzamide compounds
04/03/2014WO2014049047A1 Substituted sulfonamide compounds
04/03/2014WO2014048547A1 Alpha hydroxy amides
04/03/2014WO2014048532A1 Quinazolinone derivatives as parp inhibitors
04/03/2014WO2014048165A1 Compound as potassium channel modulator
04/03/2014WO2014048072A1 Spiro ring compounds as hepatitis c virus (hcv) inhibitors
04/03/2014WO2014047707A1 Heteroaromatic compounds, method for preparing the compounds, pharmaceutical compositions, uses and method for treating acute and chronic pain
04/03/2014WO2014015056A3 Anti-mucus drugs and uses therefor
04/03/2014WO2013187971A3 Macrocycles
04/03/2014WO2013053983A8 Protein kinase inhibitors
04/03/2014US20140094610 Process for the preparation of an hiv integrase inhibitor
04/03/2014US20140094609 Process for the preparation of an hiv integrase inhibitor
04/03/2014US20140094603 Mitotic kinesin inhibitors and methods of use thereof
04/03/2014US20140094491 Dimethyl-benzoic acid compounds
04/03/2014US20140094488 2-amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as vegf receptor kinase inhibitors
04/03/2014US20140094480 Pro-Neurogenic Compounds
04/03/2014US20140094465 Compounds as S-Nitrosoglutathione Reductase Inhibitors
04/03/2014US20140094456 Anti-fibrotic pyridinones
04/03/2014US20140093513 Methods of lowering proprotein conversate subtilisin/kexin type 9 (pcsk9)
04/03/2014US20140093453 Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors
04/02/2014EP2712866A1 1,2,4-triazine derivatives for the treatment of viral infections
04/02/2014EP2712863A1 Novel inhibitors of bacterial biofilms and related methods
04/02/2014EP2712862A1 New anti-invasive compounds
04/02/2014EP2712861A1 Thioacetate compounds, compositions and methods of use
04/02/2014EP2712358A2 Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as trka kinase inhibitors
04/02/2014EP2712291A1 N1- and n2-carbamoyl-1,2,3-triazole serine hydrolase inhibitors and methods
04/02/2014CN103703003A Novel compounds for organic electronic material and organic electroluminescent device using the same
04/02/2014CN103702996A Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
04/02/2014CN103702993A Benzamides
04/02/2014CN103702992A Method for producing tetrazole-substituted anthranilic acid diamide derivatives by reacting pyrazolic acids with anthranilic acid esters
04/02/2014CN103702991A Pyridin-2(1h)-one derivatives as jak inhibitors
04/02/2014CN103702990A 2-(2,4,5-substituted -anilino) pyrimidine derivatives as egfr modulators useful for treating cancer
04/02/2014CN103702979A 4-aryl-n-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group
04/02/2014CN103694226A Micromolecule electron transmission material based on pyridine and triazole and preparation method and organic light emitting diode
04/02/2014CN103694225A Method for synthesizing dexlansoprazol by titanium catalyst ligand
04/02/2014CN103694224A Dabigatran etexilate analog centered by fluorine-containing-group-modified benzene ring and synthesis method thereof
04/02/2014CN103694223A Method for preparing esomeprazole by one-pot method
04/02/2014CN103694222A New preparation method of S-pantoprazole sodium
04/02/2014CN103694221A Preparation method of pomalyst pomalidomide
04/02/2014CN103694220A Novel pyrazol-3-formate and synthetic method thereof
04/02/2014CN103694219A 3-halogenated ethoxy pyrazole amide compound and application thereof
04/02/2014CN103694218A Pyrimidine compound, PI3K inhibitor, pharmaceutical composition comprising PI3K inhibitor and application of inhibitor and pharmaceutical composition
04/02/2014CN103694163A Compounds capable of being adopted as potassium channel modulators
04/02/2014CN102993172B Tricyclic compound with antihistamine activity, preparation method and application
1 ... 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 ... 1080